BioMaxima S.A. (WSE:BMX)
10.14
0.00 (0.00%)
Jul 24, 2026, 5:00 PM CET
BioMaxima Balance Sheet
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 0.42 | 1.74 | 0.91 | 1.5 | 12.91 | 3 |
Cash & Short-Term Investments | 0.42 | 1.74 | 0.91 | 1.5 | 12.91 | 3 |
Cash Growth | -26.69% | 91.09% | -39.52% | -88.35% | 330.81% | -65.95% |
Other Receivables | 12.99 | - | 0 | 8.56 | 10.5 | - |
Total Trade Receivables | 12.99 | - | 0 | 8.56 | 10.5 | - |
Inventory | 14.79 | 13.62 | 13.52 | 12.77 | 12.82 | 14.02 |
Total Current Assets | 28.2 | 26.04 | 25.44 | 22.83 | 36.23 | 33.55 |
Net Property, Plant & Equipment | 49.82 | 50.37 | 50.57 | 50.58 | 37.76 | 27.87 |
Other Intangible Assets | 0.93 | 0.56 | 0.32 | 0.37 | 0.44 | 0.5 |
Other Long-Term Assets | 0.5 | - | - | - | - | - |
Total Assets | 79.45 | 77.47 | 76.34 | 73.78 | 74.42 | 61.93 |
Accounts Payable | 8.01 | 7.37 | 6.82 | 5.45 | 7.39 | 6.72 |
Short-Term Debt | 10.02 | 5.37 | 8.71 | 3.55 | 1.31 | - |
Current Portion of Long-Term Debt | 0.05 | 0.07 | 0.08 | 0 | 0 | - |
Current Portion of Leases | 0.75 | 0.78 | 0.3 | 0.25 | 0.41 | - |
Other Current Liabilities | 1.42 | 1.39 | 1.22 | 1.19 | 1.87 | 0.71 |
Total Current Liabilities | 40.48 | 29.96 | 34.27 | 20.88 | 21.95 | 34.7 |
Long-Term Debt | - | 6.48 | 5.24 | 8.61 | 3.86 | - |
Long-Term Leases | 5.36 | 1.83 | 0.36 | 0.46 | 0.25 | 17.27 |
Other Long-Term Liabilities | 5.8 | 5.98 | 6.17 | 7.31 | 6.88 | 7.18 |
Total Long-Term Liabilities | 11.25 | 14.41 | 11.87 | 16.37 | 10.99 | 15.39 |
Total Liabilities | 31.49 | 29.39 | 29.01 | 26.81 | 21.97 | 32.74 |
Common Stock | 4.19 | 4.19 | 4.19 | 4.19 | 4.33 | 4.32 |
Treasury Stock | - | 0 | 0 | 0 | -5 | - |
Additional Paid-in Capital | 9.84 | 9.84 | 9.84 | 9.84 | 9.84 | 9.84 |
Accumulated Other Comprehensive Income | 1.59 | 1.59 | 0.11 | 0.1 | 9.11 | 2.79 |
Retained Earnings | 32.34 | 32.46 | 33.18 | 32.85 | 34.18 | 12.24 |
Total Common Shareholders' Equity | 47.96 | 48.08 | 47.33 | 46.97 | 52.46 | 29.19 |
Shareholders' Equity | 95.93 | 48.08 | 47.33 | 46.97 | 52.46 | 29.19 |
Total Liabilities & Equity | 79.45 | 77.47 | 76.34 | 73.78 | 74.42 | 61.93 |
Total Debt | 16.18 | 14.53 | 14.7 | 12.86 | 5.83 | 17.27 |
Net Cash (Debt) | -15.75 | -12.79 | -13.79 | -11.36 | 7.08 | -14.28 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -3.76 | -3.05 | -3.29 | -2.63 | 1.59 | -3.19 |
Book Value | 47.96 | 48.08 | 47.33 | 46.97 | 52.46 | 29.19 |
Book Value Per Share | 11.44 | 11.47 | 11.29 | 10.88 | 11.76 | 6.51 |
Tangible Book Value | 47.03 | 47.52 | 47.01 | 46.6 | 52.02 | 28.69 |
Tangible Book Value Per Share | 11.22 | 11.33 | 11.21 | 10.79 | 11.67 | 6.40 |